Arentson-Lantz, E., Von Ruff, Z., Harvey, M., Wacher, A., & Paddon-Jones, D
Blood chemistry and pathological impact of GLP-1 RA PNP hydrogel therapeutics To assess the systemic impact and biosafety of GLP-1 receptor agonist (GLP-1 RA) therapeutics delivered via PNP hydrogels compared to traditional bolus administration, comprehensive blood chemistry panels were collected from diabetic rats at baseline (Day -1) and at the conclusion of the study (Day 43) ( Figure 6 )
How valid are the reviews online
Evidence quality across them varies considerably
On the basis of the evidence available, we hypothesise that direct stimulation of the more proximal L-cells is the predominant mechanism
Tyna Moore have sparked a discussion online about using GLP-1s off-label for conditions like autoimmune disease, GLP-1 agonists are only studied and FDA-approved for certain uses, including for weight loss